Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Conference Coverage
Amivantamab Plus Chemotherapy Prolongs Survival, Post-Progression Outcomes for Patients With Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
11/20/2024
According to second interim analysis results from the MARIPOSA-2 trial, amivantamab plus chemotherapy improved survival and post-progression outcomes compared to chemotherapy alone among patients with EGFR-mutated advanced non-small cell lung...
According to second interim analysis results from the MARIPOSA-2 trial, amivantamab plus chemotherapy improved survival and post-progression outcomes compared to chemotherapy alone among patients with EGFR-mutated advanced non-small cell lung...
According to second interim...
11/20/2024
APP Institute Oncology
Conference Coverage
The Enduring Benefit of Abemaciclib Plus Endocrine Therapy for Patients With HR-Positive, HER2-Negative High-Risk, Early Breast Cancer
11/20/2024
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned...
11/20/2024
APP Institute Oncology
Conference Coverage
Implementation of an IV Push Policy for Antibiotic Administration Within An Oncology Urgent Care Clinic
11/18/2024
Introduction of an IV push policy at an oncology urgent care clinic, led by an advanced practice provider, resulted in increased timely administration of antibiotics prior to hospitalization and a decrease in room dwell time.
Introduction of an IV push policy at an oncology urgent care clinic, led by an advanced practice provider, resulted in increased timely administration of antibiotics prior to hospitalization and a decrease in room dwell time.
Introduction of an IV push...
11/18/2024
APP Institute Oncology
Conference Coverage
Workload Index Proves Valuable in Optimizing Oncology Advanced Practitioner Resourcing
11/18/2024
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success...
11/18/2024
APP Institute Oncology
Alrlene Siefker-Radke
Conference Coverage
Beyond Platinum: Current Treatment Approaches for Advanced Bladder Cancer
11/15/2024
Arlene Siefker-Radtke, MD, provides an overview on the current treatment landscape for patients with advanced bladder cancer.
Arlene Siefker-Radtke, MD, provides an overview on the current treatment landscape for patients with advanced bladder cancer.
Arlene Siefker-Radtke, MD,...
11/15/2024
APP Institute Oncology
Conference Coverage
Weekend Infusion Model Reduces Emergency Department Visits and Length of Stay for Oncology Patients
11/14/2024
The expansion of infusion services to a weekend-inclusive model led to less emergency department visits, saved inpatient days, and reduced hospital length of stay for oncology patients, according to data presented at the 2024 JADPRO meeting.
The expansion of infusion services to a weekend-inclusive model led to less emergency department visits, saved inpatient days, and reduced hospital length of stay for oncology patients, according to data presented at the 2024 JADPRO meeting.
The expansion of infusion...
11/14/2024
APP Institute Oncology
Conference Coverage
New Patient Visits Via Telehealth Improve Management of Patients With MGUS at Increased Risk for Hematological Cancers
11/14/2024
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance (MGUS) at increased risk of...
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance (MGUS) at increased risk of...
Conducting new patient visits...
11/14/2024
APP Institute Oncology
Lorraine Drapek, Massachusetts General Hospital
Videos
The Impact of Radiation Therapy: Navigating Acute and Long-Term Side Effects
11/28/2023
Lorraine Drapek, DNP, FNP-BC, AOCNP, discusses common side effects from radiation therapy and provides guidance on managing these side effects for optimal patient care.
Lorraine Drapek, DNP, FNP-BC, AOCNP, discusses common side effects from radiation therapy and provides guidance on managing these side effects for optimal patient care.
Lorraine Drapek, DNP, FNP-BC,...
11/28/2023
APP Institute Oncology
Beth Finley-Oliver and Rachid Baz, Moffitt Cancer Center
Clinical Pearls
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
11/27/2023
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN,...
11/27/2023
APP Institute Oncology
Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement